{"id":3914,"date":"2016-07-05T09:19:37","date_gmt":"2016-07-05T07:19:37","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\/"},"modified":"2020-06-26T14:30:56","modified_gmt":"2020-06-26T12:30:56","slug":"nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\/","title":{"rendered":"Nanexa breddar PharmaShell\u00ae f\u00f6r att m\u00f6ta \u00f6nskem\u00e5l fr\u00e5n l\u00e4kemedelsindustrin"},"content":{"rendered":"
\n

<\/strong><\/span><\/p>\n<\/div>\n

Nanexa har utvecklat ett nytt skalmaterial baserat p\u00e5 det biokompatibla materialet titandioxid f\u00f6r drug delivery-systemet PharmaShell\u00ae <\/em><\/span><\/p>\n

Utvecklingen av PharmaShell\u00aehar nu resulterat i ett nytt h\u00f6gintressant skalmaterial med kompletterande egenskaper till Nanexas redan utvecklade skalmaterial. Skalmaterialet best\u00e5r av det biokompatibla materialet titandioxid och kan anv\u00e4ndas f\u00f6r tillverkningen av PharmaShell\u00ae. I vissa till\u00e4mpningsomr\u00e5den kan det vara f\u00f6rdelaktigt att anv\u00e4nda titandioxid varf\u00f6r det \u00e4r ett stort steg fram\u00e5t f\u00f6r PharmaShell\u00ae. Titandioxid \u00e4r ett v\u00e4lk\u00e4nt biokompatibelt material, och PharmaShell kan nu tillverkas med b\u00e5de aluminiumoxid och titandioxid.<\/span><\/p>\n

Den nya titandioxidytan som \u00e4r verifierad in-vitro, skyddas inom Nanexas befintliga patentportf\u00f6lj och med den nya tekniken vidgas m\u00f6jligheterna f\u00f6r PharmaShell\u00ae. Detta ger Nanexa f\u00f6ruts\u00e4ttningen att erbjuda nuvarande och framtida partners st\u00f6rre m\u00f6jligheter att skr\u00e4ddarsy l\u00f6sningar f\u00f6r drug delivery utifr\u00e5n specifika \u00f6nskem\u00e5l.<\/span><\/p>\n

Nanexas VD David Westberg \u00e4r n\u00f6jd med utvecklingen – \u201dNanexa har arbetat l\u00e4nge med att ta fram en process f\u00f6r att anv\u00e4nda titandioxid i drug delivery-systemet PharmaShell\u00ae. Nu n\u00e4r processen \u00e4r verifierad \u00f6ppnar sig nya aff\u00e4rsm\u00f6jligheter. Ett av Nanexas m\u00e5l \u00e4r att kunna erbjuda ett anpassningsbart drug delivery-system med PharmaShell\u00ae och jag vet att titandioxidskalet kommer tilltala m\u00e5nga av v\u00e5ra potentiella kunder.\u201d<\/span><\/p>\n

Bolaget bed\u00f6mer att det nya skalmaterialet f\u00f6r PharmaShell\u00ae kommer att \u00f6ka m\u00f6jligheterna till aff\u00e4rer och \u00f6ppna f\u00f6r nya till\u00e4mpningsomr\u00e5den.<\/span><\/p>\n

F\u00f6r mer information kontakta:
<\/span>David Westberg \u2013 VD, Nanexa AB (publ)\u00a0
<\/span>?Telefon: 0709 -42 83 03?
<\/span>E-post:\u00a0<\/span>david.westberg@nanexa.se<\/a>\u00a0
<\/span>www.nanexa.se<\/a>\u00a0<\/span><\/p>\n

Om Nanexa AB (publ)
<\/span>Nanexa AB \u00e4r ett h\u00f6gteknologiskt forskningsf\u00f6retag som utvecklar och marknadsf\u00f6r produkter inom nanoteknologi. Bolagets fokus ligger p\u00e5 PharmaShell\u00ae som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal omr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae har Nanexa samarbetsavtal med bland andra AstraZeneca och Uppsala universitet.<\/span><\/p>\n

\n

Bifogade filer<\/strong><\/p>\n\n

<\/a><\/p>\n<\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"<\/p>\n

Nanexa har utvecklat ett nytt skalmaterial baserat p\u00e5 det biokompatibla materialet titandioxid f\u00f6r drug delivery-systemet PharmaShell\u00ae <\/em><\/p>\n

Utvecklingen av PharmaShell\u00aehar nu resulterat i ett nytt h\u00f6gintressant skalmaterial med kompletterande egenskaper till Nanexas redan utvecklade skalmaterial.<\/p>\n

L\u00e4s mer<\/a><\/p>\n","protected":false},"template":"","class_list":["post-3914","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nNanexa breddar PharmaShell\u00ae f\u00f6r att m\u00f6ta \u00f6nskem\u00e5l fr\u00e5n l\u00e4kemedelsindustrin - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa breddar PharmaShell\u00ae f\u00f6r att m\u00f6ta \u00f6nskem\u00e5l fr\u00e5n l\u00e4kemedelsindustrin - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa har utvecklat ett nytt skalmaterial baserat p\u00e5 det biokompatibla materialet titandioxid f\u00f6r drug delivery-systemet PharmaShell\u00ae Utvecklingen av PharmaShell\u00aehar nu resulterat i ett nytt h\u00f6gintressant skalmaterial med kompletterande egenskaper till Nanexas redan utvecklade skalmaterial.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:modified_time\" content=\"2020-06-26T12:30:56+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\\\/\",\"name\":\"Nanexa breddar PharmaShell\u00ae f\u00f6r att m\u00f6ta \u00f6nskem\u00e5l fr\u00e5n l\u00e4kemedelsindustrin - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2016-07-05T07:19:37+00:00\",\"dateModified\":\"2020-06-26T12:30:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa breddar PharmaShell\u00ae f\u00f6r att m\u00f6ta \u00f6nskem\u00e5l fr\u00e5n l\u00e4kemedelsindustrin\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa breddar PharmaShell\u00ae f\u00f6r att m\u00f6ta \u00f6nskem\u00e5l fr\u00e5n l\u00e4kemedelsindustrin - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa breddar PharmaShell\u00ae f\u00f6r att m\u00f6ta \u00f6nskem\u00e5l fr\u00e5n l\u00e4kemedelsindustrin - Nanexa AB","og_description":"Nanexa har utvecklat ett nytt skalmaterial baserat p\u00e5 det biokompatibla materialet titandioxid f\u00f6r drug delivery-systemet PharmaShell\u00ae Utvecklingen av PharmaShell\u00aehar nu resulterat i ett nytt h\u00f6gintressant skalmaterial med kompletterande egenskaper till Nanexas redan utvecklade skalmaterial.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\/","og_site_name":"Nanexa AB","article_modified_time":"2020-06-26T12:30:56+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\/","name":"Nanexa breddar PharmaShell\u00ae f\u00f6r att m\u00f6ta \u00f6nskem\u00e5l fr\u00e5n l\u00e4kemedelsindustrin - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2016-07-05T07:19:37+00:00","dateModified":"2020-06-26T12:30:56+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-breddar-pharmashell-for-att-mota-onskemal-fran-lakemedelsindustrin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa breddar PharmaShell\u00ae f\u00f6r att m\u00f6ta \u00f6nskem\u00e5l fr\u00e5n l\u00e4kemedelsindustrin"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3914","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3914"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}